EPSTEIN-BARR VIRUS INFECTION REACTIVATION

This adverse event was reported 1317 times

These drugs are most commonly taken by patients reporting EPSTEIN-BARR VIRUS INFECTION REACTIVATION:

# Drug Count
0 TACROLIMUS 387
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 382
2 TACROLIMUS OINTMENT 0.1% 382
3 CYCLOSPORINE 367
4 METHOTREXATE SODIUM 357
5 FLUDARABINE PHOSPHATE 346
6 METHOTREXATE 337
7 RITUXIMAB 308
8 CYCLOPHOSPHAMIDE 305
9 CYCLOPHOSPHAMIDE FOR INJECTION 305
See all common drugs associated with EPSTEIN-BARR VIRUS INFECTION REACTIVATION

EPSTEIN-BARR VIRUS INFECTION REACTIVATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CIDOFOVIR ANHYDROUS 44 0.0304
1 TREOSULFAN 52 0.0188
2 SILTUXIMAB 9 0.0139
3 BUSULFAN 199 0.0125
4 TEPLIZUMAB-MZWV 8 0.0111
5 CLOFARABINE 24 0.0105
6 FOSCARNET SODIUM 40 0.0099
7 FLUDARABINE PHOSPHATE 346 0.0087
8 THIOTEPA 77 0.0079
9 LETERMOVIR 22 0.0068
See all drugs enriched for association with EPSTEIN-BARR VIRUS INFECTION REACTIVATION